Log In
Print
BCIQ
Print
Print this Print this
 

Byetta, exenatide

Also known as: Exendin-4 (AC2993)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionSynthetic exendin-4
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today